AI-generated summary
The authors tested photothermal therapy for ovarian cancer in mice using copper sulfide nanoparticles, tracked with PET imaging and guided by MR temperature imaging. They compared 808 nm and 980 nm near-infrared lasers and report that 980 nm produced better photothermal effects and significant tumor ablation versus no treatment in subcutaneous and orthotopic models. The authors conclude that real-time monitoring is a promising approach for future clinical translation.
- Who or what was studied
- Mouse models of ovarian cancer (subcutaneous and orthotopic)
- Wavelengths
- 808, 980 nm
- Limits stated in the abstract
- The study was conducted in animal models, and the abstract does not report a clinical or human sample.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jnm.snmjournals.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 980 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Near-infrared, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.